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Abstract
Introduction: We report on a case of autoimmune pancreatitis presenting as pancreatic head cancer, which is
extremely rare in Iran. Currently, on the PubMed database, no such cases exist.
Case presentation: A 70-year-old Iranian man presented with recurrent abdominal pain, jaundice and elevated
bilirubin and alkaline phosphatase levels. An abdominal computed tomography scan revealed a heterogeneous
presence in the pancreatic head as well as dilated intra- and extrahepatic bile ducts. A common bile duct stent
had been inserted. Our patient was subsequently diagnosed with pancreatic head cancer.
Due to his continued recurrent abdominal pain, our patient returned to the hospital. His levels of bilirubin, alkaline
phosphatase and tumor markers were all normal but his immunoglobulin G4 and antinuclear antibodies were
extremely high. A biopsy of the pancreatic head heterogeneity by endoscopic ultrasonography was performed.
Pathologic samples showed fibrosis associated with lymphoplasmacytic infiltration and no evidence of malignancy.
A diagnosis of autoimmune pancreatitis was confirmed, the bile duct stent removed, and an appropriate treatment
plan was undertaken.
Conclusion: Autoimmune pancreatitis should be considered in suspected cases of pancreatic cancer. In these
instances, a biopsy of the pancreas will help to differentiate between the two and prevent complications due to
disease progression as well as unnecessary surgery.
Introduction
Autoimmune pancreatitis (AIP) is a rare disease and has
only been reported in certain countries [1]. Cases of
autoimmune pancreatitis that mimic pancreatic head
cancer are rare in Iran.
AIP is a primary pancreatic disorder that is associated
with other autoimmune disorders, such as primary bili-
ary cirrhosis, rheumatoid arthritis, sarcoidosis, inflam-
matory bowel disease and vitiligo [2]. The disease
commonly presents as recurrent mild abdominal pain
with obstruction of the biliary ducts and pancreatic
duct; there may be a pancreatic mass that can be mis-
diagnosed as pancreatic lymphoma or cancer [3].
Although such cases are rare, an accurate diagnosis of
AIP can prevent the progression of the disease and
unnecessary surgery.
T h ed i a g n o s t i cc r i t e r i ad e f i n e db yt h eM a y oC l i n i c
include one or more of three characteristics: diagnostic
histology; related features in abdominal magnetic reso-
nance imaging (MRI) or computed tomography (CT) in
association with increased levels of immunoglobulin G4
(IgG4); and the response of intra- or extrapancreatic
manifestations to corticosteroid therapy [4].
The imaging features of the disease have similar pre-
sentations in both MRI and CT scans and may include
local or diffuse enlargement of the pancreas [5]. AIP can
appear as a common bile duct stricture in an endoscopic
retrograde cholangiopancreatography. It is impossible to
distinguish AIP from pancreatic cancer solely by means
of such imaging techniques [6].
A serum level of IgG4 above 135 ng/dL has very high
sensitivity and specificity in differentiating AIP from
pancreatic cancer [7]. However, although increased
serum levels of IgG4 and radiologic features associated
with a therapeutic response to corticosteroids are sug-
gestive of AIP, a pancreatic biopsy is essential in
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pancreatic sample include dense fibrosis and inflamma-
tory levels of lymphoplasmacytic infiltration [4].
Case presentation
Our patient was a 75-year-old Iranian man, admitted to
hospital with recurrent upper abdominal pain for the
past 18 months. A common bile duct plastic stent had
been inserted based on the results of diagnostic investi-
gations, including an obstructive pattern of liver enzyme
elevation, dilatation of extra- and intrahepatic bile ducts
revealed through ultrasonography and heterogeneity of
the pancreatic head (likely due to cancer) in an abdom-
inal spiral CT scan with oral- and venous-contrast
media (Figures 1 and 2). No abnormalities were found
during a physical examination, with the exception of
mild upper abdominal tenderness and vitiligo patches
on his neck and hands (Tables 1 and 2).
An upper gastrointestinal endoscopy, aimed at con-
trolling the presence of occult blood in his stool, iron
deficiency anemia and heartburn, showed lower esopha-
geal ulcers associated with diaphragmatic herniation. A
pathologic evaluation of the ulcer biopsy specimens con-
firmed reflux esophagitis. A colonoscopy was normal.
Mild dilatation of his extra- and intrahepatic bile ducts
was seen in repeated abdominal ultrasonography proce-
dures. However, an endoscopic ultrasound showed a
hypoechoic area, 2 cm in size, in the head of his
pancreas. The pathological and cytological results of an
aspiration biopsy of the lesion revealed fibrosis and
inflammatory cell infiltration without evidence of malig-
nancy (Figures 3 and 4).
Once AIP had been diagnosed, prednisolone was admi-
nistered. Two months after treatment, a reevaluation of
the pancreas head by means of an abdominal spiral CT
scan with oral and venous contrast media did not show
any abnormality, and the common bile duct stent was
removed because of the positive therapeutic response.
Discussion
The etiology of AIP, a rare type of chronic pancreatitis,
has been recognized by clinical, histological and mor-
phologic findings [3]. Recently, it has been described as
a systemic disease with lymphoplasmacytic infiltration
that is associated with other autoimmune diseases. The
disease has been reported in a number of countries and
its incidence has been rising in some regions, especially
in Japan [1,6].
Typically, AIP can present in various clinical forms,
including mild pancreatitis, acute recurrent pancreatitis,
biliary duct strictures and pancreatitis, with such clinical
presentations as primary sclerosing cholangitis and a
pancreatic mass, which may be misdiagnosed as pan-
creatic cancer.
Acute AIP symptoms may also include rare, intermit-
tent abdominal pain, weight loss, jaundice and an
Figure 1 CT scan before treatment. Dilatation of extra- and intrahepatic bile ducts and heterogeneity of the head of the pancreas are visible.
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rise of alkaline phosphatase relative to a mild elevation
in aminotransferases) that may also be seen in cases of
pancreatic cancer and cholangiocarcinoma [8].
AIP has been reported in two patients with obstructive
jaundice and a diagnosis of pancreatic head cancer was
made based on radiologic studies conducted by Japanese
researchers [9]. In another study, AIP was reported as
the most common benign disease in patients with a
diagnosis of pancreatic adenocarcinoma who had under-
gone a pancreatoduodenectomy [10].
The definitive diagnosis of AIP is made by radiologic
CT scan findings of a narrowing of the pancreatic duct
and parenchymal edema of the pancreas [8]; and on
MRI as a focal or diffuse expansion of the pancreas (a
sausage shape). These findings are usually associated
with an absence of vascular marking, calcification or
fluid collection around the pancreas, a narrowing of the
main pancreatic duct and a crescent development of the
pancreas head [5].
AIP is routinely responsive to corticosteroid therapy
over a one to four month period [7]. During treatment,
patients typically have an immunological follow-up with
an assessment of serum levels of IgG4 through a CT scan.
Conclusion
AIP is an autoimmune disease with varying diagnostic
criteria, which include a range of pancreatic
Figure 2 CT scan before the treatment. See the heterogeneity of the head of pancreas.
Table 1 The results of laboratory tests before the stent
placement.
Product Level
Aspartate aminotransferase 110 U/L
Alanine aminotransferase 120 U/L
Alkaline phosphatase 540 IU
Total bilirubin 4.5 mg/dL
Direct bilirubin 2.5 mg/dL
Amylase 450 IU
Table 2 The laboratory test results after the stent
placement.
Test Level
Aspartate aminotransferase 21 U/L
Alanine aminotransferase 10 U/L
Alkaline phosphatase 250 IU
Total bilirubin 0.6 mg/dl
Direct bilirubin 0.2 mg/dl
Amylase 100 IU
White blood cell count 4100 cells/mm
Hemoglobin 311 g/dL
Mean corpuscular volume 76 fL
Erythrocyte sedimentation rate 36 mm/h
Blood urea nitrogen 18 mg/dL
Creatinine 1 mg/dL
Serum iron 25 mg/dL
Total iron binding capacity 468
Immunoglobulin G4 187 ng/mL
Carcinoembryonic antigen 2.7 ng/mL
Carbohydrate antigen 125 16 ng/mL
Carbohydrate antigen 19-9 8 ng/mL
Alpha fetoprotein 2.5 ng/5 mL
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biopsy, increased IgG4 serum level and a therapeutic
response to corticosteroids are necessary in determining
a definitive differentiation from a diagnosis of pancreatic
adenocarcinoma based on radiologic findings [4]. A pre-
cise diagnosis of AIP would prevent complications aris-
ing from the progression of the disease and unnecessary
surgery [4,10].
Figure 3 Pathologic evaluation of the pancreas biopsy specimen. The specimen shows fibrosis and lymphoplasmacytic infiltration without
evidence of malignancy.
Figure 4 Pathologic findings of the pancreas biopsy specimen. Lymphoplasmacytic infiltration of the sample is visible.
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